LPCN Stock Analysis: Buy, Sell, or Hold?

LPCN - Lipocine Inc.

PHARMACEUTICAL PREPARATIONS
$2.39
-0.07 (-2.85%) ▼
5d: +0.42%
30d: +6.22%
90d: -74.16%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026 29d

Get Alerted When LPCN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: LPCN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: LPCN is currently trading at $2.39, which is considered slightly high relative to its 30-day fair value range of $2.14 to $2.44.

Technical Outlook: Technically, LPCN is in a strong downtrend. The price is approaching resistance at $2.37. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: LPCN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+151.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $2.14 - $2.44
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 78.9%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 151.0% below Wall St target ($6.00)

Trading Range Analysis

30-Day Trading Range $2.14 - $2.44
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $2.01
Resistance Level $2.37
Current Trend Strong Downtrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.45
Wall Street Target $6.00 (+151.0%)
Revenue Growth (YoY) 27.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 05, 2026 12:46 PM ET
Data refreshes hourly during market hours. Next update: 1:46 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John W Higuchi BUY 40000 shares 2026-04-07
John W Higuchi BUY 123000 shares 2026-04-06
Mahesh V Patel BUY 25000 shares 2026-04-06

Unlock Insider Activity

See real-time buying/selling by company executives for LPCN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$549 59 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$108 64 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 54 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 45 HOLD
RVMD
Revolution Medicines Inc
STRONG BUY
12 analysts
$197 62 BUY

More Analysis for LPCN

LPCN Technical Chart LPCN Price Prediction LPCN Earnings Date LPCN Investment Advisor LPCN Fair Price Analyzer LPCN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals